000 01287 a2200349 4500
005 20250514034605.0
264 0 _c20021210
008 200212s 0 0 eng d
022 _a1083-7450
024 7 _a10.1081/pdt-120003487
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAmiji, Mansoor M
245 0 0 _aIntratumoral administration of paclitaxel in an in situ gelling poloxamer 407 formulation.
_h[electronic resource]
260 _bPharmaceutical development and technology
_cMay 2002
300 _a195-202 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents, Phytogenic
_xadministration & dosage
650 0 4 _aChemistry, Pharmaceutical
650 0 4 _aGels
650 0 4 _aMelanoma, Experimental
_xdrug therapy
650 0 4 _aMice
650 0 4 _aMice, Inbred C57BL
650 0 4 _aPaclitaxel
_xadministration & dosage
650 0 4 _aPoloxamer
_xadministration & dosage
650 0 4 _aSolubility
700 1 _aLai, Phung-Kim
700 1 _aShenoy, Dinesh B
700 1 _aRao, Mahadev
773 0 _tPharmaceutical development and technology
_gvol. 7
_gno. 2
_gp. 195-202
856 4 0 _uhttps://doi.org/10.1081/pdt-120003487
_zAvailable from publisher's website
999 _c11961878
_d11961878